⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ZTS

Zoetis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

81.03USD

-0.9700 (-1.18%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ZTS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.51▼$1.84013
Next quarter$1.31▼$1.64013
Current year$6.21▼$6.87015
Next year$6.45▼$7.39015

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.85$1.87+0.02 (+1.0%)
2026-03-31$1.62$1.53-0.09 (-5.3%)
2025-12-31$1.4$1.48+0.08 (+5.5%)
2025-09-30$1.62$1.7+0.08 (+4.8%)

Wall Street coverage

232 ratings from 34 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
JefferiesDowngraded from BuyHold$103 $83Oct 20, 2026
Goldman SachsInitiatedNeutral$74Oct 16, 2026
TD CowenMaintainedBuy$104 $94Aug 25, 2026
StifelMaintainedHold$85 $80Aug 20, 2026
CitigroupMaintainedBuy$112 $96Aug 11, 2026
BNP ParibasMaintainedOutperform$146 $110Aug 11, 2026
Piper SandlerMaintainedNeutral$90 $80Aug 10, 2026
UBSMaintainedNeutral$85 $80Aug 7, 2026
JP MorganMaintainedOverweight$130 $115Aug 7, 2026
William BlairDowngraded from OutperformMarket Perform—Aug 6, 2026
UBSMaintainedNeutral$99 $85Jul 27, 2026
Morgan StanleyMaintainedOverweight$115 $99Jul 22, 2026
HSBCMaintainedBuy$140 $95Jul 6, 2026
BarclaysMaintainedEqual-Weight$136 $85Jul 1, 2026
TD CowenMaintainedBuy$150 $104Jun 30, 2026
StifelMaintainedHold$95 $85Jun 26, 2026
Argus ResearchDowngraded from BuyHold—May 27, 2026
StifelMaintainedHold$105 $95May 22, 2026
CitigroupMaintainedBuy$145 $112May 18, 2026
UBSMaintainedNeutral$130 $99May 8, 2026
JP MorganMaintainedOverweight$190 $130May 8, 2026
UBSMaintainedNeutral$136 $130Apr 28, 2026
CitigroupInitiatedBuy$145Apr 15, 2026
B of A SecuritiesMaintainedNeutral$135 $140Feb 13, 2026
Piper SandlerDowngraded from OverweightNeutral$190 $135Jan 22, 2026

Insider transactions

105 filings from 31 insiders · 0 buy / 0 sell over 6m

Officers and directors of ZTS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
PECK KRISTIN CDirector; Officer, Chief Executive OfficerGrantPhantom Stock Unit720.144$26.17$19kOct 9, 2026
Esch KevinOfficer, Executive Vice PresidentGrantPhantom Stock Unit360.073$26.17$9kOct 9, 2026
Driscoll RimmaOfficer, Executive Vice PresidentGrantPhantom Stock Unit277.772$26.17$7kOct 9, 2026
FULLER JULIEOfficer, Executive Vice PresidentGrantPhantom Stock Unit367.788$26.17$10kOct 9, 2026
Sarbaugh KeithOfficer, Executive Vice PresidentGrantPhantom Stock Unit303.49$26.17$8kOct 9, 2026
Ferran Astorga JeannetteOfficer, Executive Vice PresidentGrantPhantom Stock Unit52.983$26.17$1kOct 9, 2026
Nayak Abhay UOfficer, Executive Vice PresidentGrantPhantom Stock Unit321.495$26.17$8kOct 9, 2026
Lagano RoxanneOfficer, Executive Vice PresidentGrantPhantom Stock Unit367.788$26.17$10kOct 9, 2026
FULLER JULIEOfficer, Executive Vice PresidentExercise799——Sep 30, 2026
FULLER JULIEOfficer, Executive Vice PresidentTax274$69.83$19kSep 30, 2026
FULLER JULIEOfficer, Executive Vice PresidentExerciseRestricted Stock Unit799.071——Sep 30, 2026
Stetter MarkDirectorGrantPhantom Stock Unit342.372$73.02$25kSep 17, 2026
SACCARO JAMESOfficer, EVP, CFO & COOGrantRestricted Stock Unit81.1k——Aug 31, 2026
D AMELIO FRANK ADirectorGift6.7k——Aug 7, 2026
MCCALLISTER MICHAEL BDirectorGift1.2k——Jun 10, 2026
STETTER MARKDirectorOther1.6k——May 21, 2026
PARENT LOUISE MDirectorOther12.1k——May 20, 2026
BISARO PAUL M.DirectorBuy2.0k$75.88$152kMay 13, 2026
D AMELIO FRANK ADirectorBuy6.7k$75.39$501kMay 13, 2026
MCCALLISTER MICHAEL BDirectorBuyindirect3.0k$77.76$233kMay 11, 2026

Analyst Notes

Sign in to write

No analyst notes on ZTS yet.

Analyst Ratings

14 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current331100Buy2.47
1 mo ago44900Buy2.29
2 mo ago45900Buy2.28
3 mo ago38900Buy2.30
Price target$93.00$74.00 – $155.00
+14.8% to target

Top voices on ZTS

Members whose judged calls on ZTS have played out most reliably.

No settled calls on ZTS yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice